Descrizione

Protein engineering is the process by which a researcher modifies a protein sequence through substitution, insertion, or deletion of nucleotides in the encoding gene, with the goal of obtaining a modified protein that is more suitable for a particular application or purpose than the unmodified protein. The global protein engineering market is poised to grow by US$ 1,099.2 milioni da 2022 A 2028, registrando un CAGR di 9.2% durante il periodo di previsione, secondo StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for protein engineering. The global protein engineering market is segmented on the basis of product, tecnologia, applicazione, end user, e regione. Per prodotto, the global protein engineering market has been segmented into instruments, reagents, software & servizi. In 2021, the reagents segment made up the largest share of revenue generated by the protein engineering market. Based upon technology, the global protein engineering market is categorized into directed evolution, rational protein design. The rational protein design segment was the largest contributor to the global protein engineering market in 2021. On the basis of application, the global protein engineering market has been segmented into coagulation factors, colony stimulating factors, growth factors, insulin, interferon, monoclonal antibodies, vaccines, altri. By end user, the global protein engineering market has been segmented into academic & research institutes, contract research organizations (CROs), pharmaceutical & biopharmaceutical companies. The pharmaceutical & biopharmaceutical companies segment held the largest share of the global protein engineering market in 2021 e si prevede che manterrà la sua quota durante il periodo di previsione. In termini di geografia, the global protein engineering market has been segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW).

The global protein engineering market is highly competitive. As of 2021, the major players in the global protein engineering market were Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, GenScript Biotech Corporation, Merck KGaA, PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the protein engineering market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: instruments, reagents, software & servizi
Tecnologia: directed evolution, rational protein design
Applicazione: coagulation factors, colony stimulating factors, growth factors, insulin, interferon, monoclonal antibodies, vaccines, altri
Utente finale: accademico & research institutes, contract research organizations (CROs), pharmaceutical & biopharmaceutical companies
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global protein engineering market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Protein engineering market overview
Parte 3. Ripartizione del mercato per prodotto
– Strumenti
– Reagents
– Software & servizi
Parte 4. Market breakdown by technology
– Directed evolution
– Rational protein design
Parte 5. Market breakdown by application
– Coagulation factors
– Colony stimulating factors
– Growth factors
– Insulin
– Interferon
– Monoclonal antibodies
– Vaccines
– Altri
Parte 6. Market breakdown by end user
– Academic & research institutes
– Contract research organizations (CROs)
– Pharmaceutical & biopharmaceutical companies
Parte 7. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 8. Aziende chiave
– Agilent Technologies, Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– GenScript Biotech Corporation
– Merck KGaA
– PerkinElmer Inc.
– Promega Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
Informazioni su StrategyHelix
Disclaimer